Contracts Finder · Award

IMMUNOGLOBULIN HOMECARE SERVICES

A public procurement published by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST via Contracts Finder.

Contracts FinderAward
£51.4k
Award value
£51.4k
Tender value
1
Suppliers
1
Awards
1
Notices
Award
Stage

Overview

For Immunoglobulin Homecare Services, procured under the Framework Agreement for the Provision of Homecare Medicines Services for Immunoglobulin Therapies 2020/S 127-312140 (East of England NHS Collaborative Procurement Hub.

Key details

Source
Contracts Finder
Lifecycle stage
Award
Status
complete
CPV classification
85149000 — Pharmacy services
Currency
GBP
Total award value
£51,438
Tender value
£51,438
First published
9 Nov 2023
Last updated
9 Nov 2023
View the original notice

Awards

1 award recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
SCIENSUS PHARMA SERVICES LIMITED0275960930 Oct 2023active£51.4k

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award noticeIMMUNOGLOBULIN HOMECARE SERVICES

All suppliers

Frameworks & programmes

More from HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST

FAQs about this procurement

Who is the buyer for "IMMUNOGLOBULIN HOMECARE SERVICES"?

IMMUNOGLOBULIN HOMECARE SERVICES is a UK public-sector procurement published by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST via Contracts Finder.

Has "IMMUNOGLOBULIN HOMECARE SERVICES" been awarded?

Yes — 1 award is recorded, with a reported total value of £51,438. The current lifecycle stage is "Award".

Which suppliers are involved in "IMMUNOGLOBULIN HOMECARE SERVICES"?

1 supplier is linked: SCIENSUS PHARMA SERVICES LIMITED.

What is "IMMUNOGLOBULIN HOMECARE SERVICES" worth?

The reported award value is £51,438.

When was "IMMUNOGLOBULIN HOMECARE SERVICES" published?

It was first published on 9 Nov 2023 and last updated on 9 Nov 2023, across 1 notice.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable